stockmarketproxy
/
TEVANYSE,OTC SEC EDGAR

TEVA PHARMACEUTICAL INDUSTRIES LTD

Pharmaceutical Preparations·TEL AVIV·FY end 12/31·CIK 818686
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

12 members · 11 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Dr. Sol J. BarerChair11y78$599,998
Richard D. FrancisCEO and Director3y57
Rosemary A. CraneDirector11y66CompTech$389,987
Amir ElsteinDirector17y70NCGAuditFinance$392,487
Chen LichtensteinDirector2y58AuditFinanceCompliance$382,487
Gerald M. LiebermanDirector11y79AuditCompFinance$414,987
Roberto A. MignoneDirector9y54NCGFinanceAudit$399,987
Dr. Perry D. NisenDirector9y70TechComplianceComp$394,987
Prof. Ronit Satchi-FainaroDirector8y54TechComplianceNCG$379,987
Prof. Varda ShalevDirectorComplianceFinance$369,987
Janet S. VergisDirectorCompNCGComplianceFinance$394,987
Dr. Tal ZaksDirector5y60FinanceTechNCGCompliance$374,987

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.